Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy have?
Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy has 65 citations in the OpenAlex counts ScholarIQ stores.
When was Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy published?
Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy has 2023 year in the ScholarIQ index.
What is the open-access status of Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy?
Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy has gold oa status in the ScholarIQ index.
What is the DOI of Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy?
The DOI for Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy is on the source record.
What is the PMID of Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy?
The PMID for Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy is on the source record.
What is the OpenAlex record for Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy?
The OpenAlex for Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy is on the source record.